Gossamer Bio Growth, Revenue, Number of Employees and Funding
Revenue & Financials
- Gossamer Bio's revenue is currently $6M per year.
- Gossamer Bio received $230.0M in venture funding in July 2018.
- Gossamer Bio's revenue per employee is $53496
- Gossamer Bio's total funding is $480M.
- Gossamer Bio has 113 Employees.
- Gossamer Bio grew their employee count by 190% last year.
- Gossamer Bio currently has 12 job openings.
What Is Gossamer Bio?
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio's strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Advanced Cell D...||$23.9M||166||8%|
|Full Spectrum A...||$5.7M||39||5%|
Gossamer Bio News
Gossamer Bio, Inc. (NASDAQ:GOSS) recently ticked higher on weak volume. About 226421 contracts were traded on 18-Mar-19 compared to
Gossamer Bio Inc (NASDAQ:GOSS) shares gapped up before the market opened on Monday . The stock had previously closed at $20.46, but
Volatility Insights. Watching some historical volatility numbers on shares of Gossamer Bio (GOSS) we can see that the 30 days volatility is
Gossamer Bio Funding
Gossamer Bio Executive Hires
|2018-07-24||Sheila Gujrathi||Chief Executive Officer, and Co-Founder||Article|
|2018-09-06||Luisa Salter-Cid||Chief Scientific Officer||Article|
|2018-12-18||Jakob Dupont||Chief Medical Officer||Article|